FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

125699003: Samarium (153-Sm) lexidronam (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3649129010 Samarium (153-Sm) lexidronam (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3649130017 Samarium (153-Sm) lexidronam en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3414201000005112 samarium (^153^Sm) lexidronam da Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Samarium (153-Sm) lexidronam (substance) Is a radioisotopmiddel til diagnose OG/ELLER behandling false Inferred relationship Some
Samarium (153-Sm) lexidronam (substance) Is a antineoplastisk middel false Inferred relationship Some
Samarium (153-Sm) lexidronam (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some
Samarium (153-Sm) lexidronam (substance) Is a Samarium-153 (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing samarium (153-Sm) lexidronam (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Samarium (153-Sm) lexidronam (substance) Inferred relationship Some 1
samarium (^153^Sm) lexidronam, injektionsvæske, opløsning, hætteglas a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Samarium (153-Sm) lexidronam (substance) Inferred relationship Some
Intravenous radionuclide therapy using samarium Sm 153 lexidronam (procedure) Direct substance True Samarium (153-Sm) lexidronam (substance) Inferred relationship Some 3
Product containing only samarium (153-Sm) lexidronam (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Samarium (153-Sm) lexidronam (substance) Inferred relationship Some 1
Samarium (153-Sm) lexidronam pentasodium This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Samarium (153-Sm) lexidronam (substance) Inferred relationship Some
Product containing samarium (153-Sm) lexidronam in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Samarium (153-Sm) lexidronam (substance) Inferred relationship Some 1
Samarium (153-Sm) lexidronam only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Samarium (153-Sm) lexidronam (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start